Drugs · acquisition-cost intelligence
NITRO-DUR
nitroglycerin· ingredient nitroglycerinMuscle relaxants· NITROGLYCERIN 120 mg/1; NITROGLYCERIN 160 mg/1; NITROGLYCERIN .1 mg/h; NITROGLYCERIN 20 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.71182
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other nitroglycerin products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Nitrostat | $0.08150 | −$0.63030 |
| Basic Dental Emergency Kit | $0.13796 | −$0.57390 |
| NITRO-BID | $1.23 | +$0.52240 |
| Rectiv | $8.52 | +$7.81 |
| nitroglycerin lingual | $23.27 | +$22.55 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.